PHARMALEADS

DENKI

In the statement, classes 1 and 42 have been corrected per the Restriction dated March 19, 2020, and per the Fnote dated April 13, 2020.;Chemical products for use in industry and science, [ all aforementioned goods only for dual enkephalinase inhibitors ] * all the aforesaid goods exclusively in connection with dual enkephalinase inhibitors *;scientific technological services namely, scientific research, analysis, testing in the field of endogenous opioid peptides; scientific research and design and development services related to the inhibition of the degradation of endogenous opioid peptides, all in the medical and pharmaceutical fields; development of medicines for [ others ] * third parties * ; medicine discovery services in the nature of development of pharmaceutical preparations, [ all aforementioned services only for dual enkephalinase inhibitors ] * all the aforesaid services exclusively in connection with dual enkephalinase inhibitors *;

FLUOFAST

Chemicals for use in industry and science, namely chemical preparations in the treatment of plants and soils; chemicals for use in the treatment of rivers, ponds, swimming pools, spa waters, tap waters and bottled waters; diagnosis preparations adapted for scientific use; enzymes, namely, proteases zinc metallopeptidases, phosphatases, and kinases, meant to be used in diagnosis products adapted for a scientific, medical or veterinary use, or for research; enzymatic or cellular preparations adapted for industrial use, namely, for use in the medical, pharmaceutical, chemical, food processing and manufacturing industries; microorganism cultures, namely, bacteria for scientific research in the field of detection and quantification of bacteria; chemical for laboratory analyses , namely, reagents adapted for scientific research in the field of enzyme detection and characterization;Scientific research and applied research, in the fields of medical, biomedical, chemical, pharmaceutical, cosmetics, veterinary, agri-food and agriculture; implementation for third parties of detection tests for the presence of toxins; license granting of intellectual property rights for others; development of software for scientific research; implementation for third parties of clinical trials; expert witness services in the pharmaceutical and scientific fields; conducting scientific studies in the field of synthesis, selection, validation, development of pharmaceutical products or diagnosis products adapted for medical, scientific or industrial use; drawing up scientific and technical opinions in the field of synthesis, selection, validation, development of pharmaceutical products or diagnosis products adapted for medical, scientific or industrial use; services of quality control for others;